Mainz University Medical Center implanted the first motor-controlled heart valves in Europe

Innovative new treatment option for narrowed aortic valves is first used in Mainz

Patients of the Mainz University Medical Center with heart valve disease have recently been able to benefit from a new treatment option for a narrowed aortic valve. Since the beginning of January 2019, cardiologists have implanted a new motor-driven and self-expanding heart valve in three patients in Europe for the first time. The advantage: the valve can be implanted more easily and safely, and leakages after implantation are further minimized. Due to increasing life expectancy, more and more people in Germany are suffering from a symptomatic constriction of the aortic valve. The so-called aortic valve stenosis is the most common heart valve defect of the elderly patient. The standard therapy, especially in younger patients, has been a cardiac-surgical valve replacement. In the last five years the numbers of catheter-assisted aortic valve replacement therapy (TAVI) have increased tremendously, in particular because of a high proportion of older, partly pre-operated patients. In 2018, there were nearly 20,000 interventions of this kind in Germany. The Department of Cardiology of the Mainz University Medical Center occupies a leading position in the field of minimally invasive heart valve therapy with more than 700 interventions per year. Around 400 TAVI procedures were carried out here last year. Now cardiologists report the first implantations of the latest model of a self-expanding aortic valve (CENTERA®) in Mainz. The new heart valve has several advantages for patients:  ·         Its special shape facilitates access to the coronary arteries and reduces leakage near the valve. ·         An active bendable catheter system also allows gentle control over the aortic arch. In addition, it is the first heart valve that allows controlled release of the heart valve with a very short nitinol scaffold, an alloy of real titanium and nickel with an electric motor. The first three implantations were performed in Mainz by Dr. Ralph Stephan von Bardeleben, Dr. Alexander Tamm, and Professor Andres Beiras-Fernandez on patients aged 73 to 91, two women and one man. Dr. von Bardeleben, head of the Department of Structural Heart Disease and Interventional Heart Valve Therapy, names it "another important step towards a highly accurate and gentle implantation technique that can now largely eliminate potential complications of the procedure in the mostly elderly patients." "The opportunity to implant the first motor-driven heart valves here in Mainz as Europe's first center is an expression of our great expertise and will help us to further expand our national top position in the field of highly innovative minimally invasive heart valves," commented Professor Thomas Münzel, Director of the Department of Cardiology at the Mainz University Medical Center. Images: http://www.uni-mainz.de/bilder_presse/04_unimedizin_kardiologie_herzklappenzentrum_team.jpg The team of the Heart Valve Center of the Mainz University Medical Center: (fltr) Dr. Felix Kreidel, Dr. Tobias Ruf, Dr. Stephan von Bardeleben, Professor Andres Beiras Fernandez, Dr. Alexander Tamm, and Dr. Angela Kornberger
photo: Peter Pulkowski Contact
Dr. Ralph Stephan von Bardeleben Head of the Department of Structural Heart Disease and Interventional Heart Valve Therapy Department of Cardiology I
Mainz University Medical Center Langenbeckstr. 1
55131 Mainz, GERMANY phone +49 6131 17-5737
e-mail: stephan.von_bardeleben@unimedizin-mainz.de
e-mail: Herzklappen@unimedizin-mainz.de Press contact Dr. Renée Dillinger-Reiter,
Corporate Communications
Mainz University Medical Center
Langenbeckstr. 1
55131 Mainz, GERMANY
phone +49 6131 17-7424
fax +49 6131 17-3496
e-mail: pr@unimedizin-mainz.de http://www.unimedizin-mainz.de/index.php?id=240&L=1 About the University Medical Center of Johannes Gutenberg University Mainz
The University Medical Center of Johannes Gutenberg University Mainz is the only medical facility providing supramaximal care in Rhineland-Palatinate while also being an internationally recognized hub of medical science. It has more than 60 clinics, institutes, and departments that collaborate across the various disciplines. Highly specialized patient care, research, and teaching form an integral whole at the Mainz University Medical Center. Approximately 3,400 students are trained in medicine and dentistry in Mainz. With its approximately 8,000 employees, the Mainz University Medical Center is also one of the largest employers in the region and an important driver of growth and innovation. Further information is available online at http://www.unimedizin-mainz.de/index.php?id=240&L=1

About the University Medical Center of the Johannes Gutenberg University Mainz
The University Medical Center of the Johannes Gutenberg University Mainz is the only medical institution of supra-maximum supply in the German state of Rhineland-Palatinate and an internationally recognized science location. Medical and scientific specialists at more than 60 clinics, institutes and departments work interdisciplinarily to treat around 340,000 patients per year. Highly specialized patient care, research and teaching are inseparably intertwined. More than 3,600 medicine and dentistry students as well as around 630 future medical, commercial and technical professionals are trained in Mainz. With a workforce of approximately 8,700 colleagues the University Medical Center Mainz is one of the largest employers in the region and an important driver of growth and innovation.
[2023]